The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Dragonfly Therapeutics; Petra Pharma; Sanofi; Surrozen
Leadership - Surrozen
Stock and Other Ownership Interests - Dragonfly Therapeutics; Petra Pharma; Surrozen
Honoraria - Sanofi
YES1 amplification as a mechanism of acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKIs) identified by a transposon mutagenesis screen and clinical genomic testing.
 
Pang-Dian Fan
No Relationships to Disclose
 
Giuseppe Narzisi
No Relationships to Disclose
 
Anitha Jayaprakash
Employment - Girihlet Inc.
Leadership - Girihlet Inc.
Stock and Other Ownership Interests - Girihlet Inc.
Patents, Royalties, Other Intellectual Property - Girihlet Inc.; Icahn School of Medicine
 
Elisa Venturini
No Relationships to Disclose
 
Nicolas Robine
No Relationships to Disclose
 
Peter Smibert
No Relationships to Disclose
 
Soren Germer
No Relationships to Disclose
 
Emmet Jordan
No Relationships to Disclose
 
Lu Wang
Consulting or Advisory Role - Roche
 
Achim A Jungbluth
Patents, Royalties, Other Intellectual Property - Ludwig Institute for Cancer Research
 
Lee Spraggon
Patents, Royalties, Other Intellectual Property - Memorial Sloan-Kettering Cancer Center
 
Christine Marie Lovly
Honoraria - NCCN; Novartis; Pfizer; Qiagen; Sequenom
Consulting or Advisory Role - Ariad; ARIAD; Clovis Oncology; Genoptix; Novartis; Novartis
Research Funding - AstraZeneca; Novartis
Travel, Accommodations, Expenses - Pfizer
 
Mark G. Kris
Consulting or Advisory Role - ARIAD; AstraZeneca; Genentech/Roche
Research Funding - Genentech/Roche (Inst); Puma Biotechnology (Inst)
 
Helena Alexandra Yu
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly
Research Funding - Astellas Pharma; AstraZeneca; Clovis Oncology; Incyte; Lilly
 
Gregory J. Riely
Consulting or Advisory Role - Genentech; Novartis; Novartis; Roche
Research Funding - ARIAD (Inst); GlaxoSmithKline (Inst); Infinity Pharmaceuticals (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Novartis
 
Harold Varmus
No Relationships to Disclose
 
Katerina A. Politi
Consulting or Advisory Role - Novartis
Research Funding - AstraZeneca; Kolltan Pharmaceuticals; Roche
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a patent licensed by MSKCC to Molecular MD for T790M testing
Travel, Accommodations, Expenses - Novartis
 
Marc Ladanyi
Honoraria - Merck (I)
Consulting or Advisory Role - NCCN/AstraZeneca; NCCN/Boehringer Ingelheim
Research Funding - Loxo (Inst)